Sign up to save your podcasts
Or
Share Vaccine Progress and What’s Next
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Vaccine Progress and What’s Next
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
View all episodes
By Goldman Sachs
4.2
912912 ratings
Salveen Richter, lead analyst for the US Biotechnology sector in Goldman Sachs Research, talks about Pfizer’s clinical-trial results for its COVID-19 vaccine and the obstacles that still lie ahead for FDA approval and widespread distribution.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More shows like Exchanges
View all
Bloomberg Surveillance
1,183 Listeners
Masters in Business
2,172 Listeners
Odd Lots
1,890 Listeners
Notes on the Week Ahead
195 Listeners
Insights Now
95 Listeners
Capital Allocators – Inside the Institutional Investment Industry
795 Listeners
Wall Street Breakfast
1,038 Listeners
Talks at GS
83 Listeners
UBS On-Air: Market Moves
182 Listeners
Making Sense
60 Listeners
Thoughts on the Market
1,300 Listeners
At Any Rate
77 Listeners
The Memo by Howard Marks
447 Listeners
Global Data Pod
29 Listeners
The Markets
74 Listeners